Moolec Science SA (NASDAQ: MLEC)

Sector: Healthcare Industry: Biotechnology CIK: 0001937737
Market Cap 18.91 Mn
P/B 0.07
P/E -0.34
P/S 0.06
Div Yield % 0.00

About

Moolec Science SA, known by its ticker symbol MLEC, operates in the food technology industry, specializing in the development, manufacturing, marketing, and distribution of science-based food ingredients, including animal proteins produced using animal-free ingredients. The company's main business activities are centered on the development of molecular farming-derived products, a process that involves the use of animal DNA within plants to create animal proteins within the plants themselves. The company generates revenue through the sale of its...

Read more

Price action

Investment thesis

Bull case

No data available.

Bear case

No data available.

Peer comparison

Companies in the Biotechnology
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 SMMT Summit Therapeutics Inc. 1,446.17 Bn -1,569.17 0.00 0.01 Bn
2 ONC BeOne Medicines Ltd. 439.23 Bn 6,407.40 88.33 1.90 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma 120.62 Bn 32.82 10.29 1.83 Bn
4 REGN Regeneron Pharmaceuticals, Inc. 84.40 Bn 18.44 5.92 2.71 Bn
5 ALNY Alnylam Pharmaceuticals, Inc. 56.13 Bn 1,288.39 17.49 3.21 Bn
6 ARGX Argenx Se 47.89 Bn 31.79 24,973.95 -
7 BNTC Benitec Biopharma Inc. 42.45 Bn -1,015.00 0.00 0.00 Bn
8 INSM INSMED Inc 32.67 Bn -27.60 73.08 0.74 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 0.05 12.96
EV to Cash from Ops. EV/CFO 0.78 23.73
EV to Debt EV to Debt 0.14 772.65
EV to EBIT EV/EBIT -1.54 -11.30
EV to EBITDA EV/EBITDA 1.85 7.11
EV to Free Cash Flow [EV/FCF] EV/FCF 1.08 22.12
EV to Market Cap EV to Market Cap 2.07 68.89
EV to Revenue EV/Rev 0.12 199.70
Price to Book Value [P/B] P/B 0.07 22.62
Price to Earnings [P/E] P/E -0.34 -12.30
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 -12.02
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 0.17
Dividend per Basic Share Div per Share (Qtr) 0.00 0.01
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 -0.15
Interest Coverage Int. cover (Qtr) -0.88 857.11
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 34.93 -27.24
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -26.48 747.06
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.01
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -239.69 -48.21
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -66.60 -2.09
EBIT Growth (1y) % EBIT 1y % (Qtr) -172.45 -57.79
EBT Growth (1y) % EBT 1y % (Qtr) -772.22 -14.35
EPS Growth (1y) % EPS 1y % (Qtr) -1,384.31 -30.88
FCF Growth (1y) % FCF 1y % (Qtr) 76.59 -32.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -29.34 227.96
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.44 0.14
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.00
Cash Ratio Cash Ratio (Qtr) 0.10 3.79
Current Ratio Curr Ratio (Qtr) 0.91 7.23
Debt to Equity Ratio Debt/Equity (Qtr) 1.04 0.42
Interest Cover Ratio Int Coverage (Qtr) -0.88 857.11
Times Interest Earned Times Interest Earned (Qtr) -0.88 857.11
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) -0.90 -18,509.94
EBIT Margin % EBIT Margin % (Qtr) -7.55 -18,862.18
EBT Margin % EBT Margin % (Qtr) -16.16 -19,783.19
Gross Margin % Gross Margin % (Qtr) 38.80 -8.62
Net Profit Margin % Net Margin % (Qtr) -16.50 -19,732.60